Kursprognose für ABVC Biopharma Inc (ABVC)ABVCABVC Biopharma Inc

Alphio's ABVC stock price prediction model matches the current ABVC Biopharma Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.97 (-0.89%). The 1-week path is $0.98 (+0.47%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

ABVC Biopharma Inc is currently trading at $0.98, which is significantly lower than its 52-week high of $3.06, indicating a potential undervaluation. However, the stock has a low RSI of 36.75, suggesting it is nearing oversold territory, but it has also experienced a substantial year-to-date decline of 55.25%. The company has reported no revenue for several quarters, and its forward P/E ratio is 0, indicating uncertainty about future earnings. The main risk is the negative net income trend, with losses reaching -$3.56 million in Q4 2025. Therefore, while there are signs of potential recovery, the lack of revenue and ongoing losses suggest a cautious approach is warranted.

ABVC Biopharma Inc (ABVC) last closed at $0.98, gaining +0.91%. These facts feed the 1-day and 1-week ABVC price prediction above.